Navigation Links
Active Life Announces Launch of Next Generation BioDentTM for Life Science Research
Date:9/18/2012

SANTA BARBARA, Calif., Sept. 18, 2012 /PRNewswire-iReach/ -- Active Life Scientific, Inc. announced today the launch of the next generation Reference Point Indenter, BioDentTM Hfc, to occur on October 12 at the 2012 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in Minneapolis, Minnesota.

BioDentTM provides life science researchers previously impossible means to measure material properties of tissues in vivo.  "By listening to the needs of top life scientists world-wide, we developed a one-of-a-kind product for researchers," said Davis Brimer, Active Life's Chief Executive Officer.  "BioDentTM users are at the forefront of research and are quickly gaining a competitive edge in their field.  The next generation BioDentTM provides an excellent entry point for collecting increasingly important tissue-level material property data."

Applications are under development for measuring material properties of a multitude of tissues.  Initially, Active Life is focused on supporting bone tissue applications, making ASBMR an ideal launch location.  "Several key opinion leader BioDentTM users were selected to present their groundbreaking research at the conference," said Chris Mazzochi, PhD, Active Life's Field Applications Scientist. "These presentations highlight the growing value of Reference Point Indentation data in bone research.  The intuitive BioDentTM Hfc interface has enabled initial users to spend little time learning the technology, thereby maximizing their time collecting and reporting important results."

About Active Life

Active Life Scientific, Inc., a Santa Barbara, CA based company, is developing life science and medical tools for previously impossible in vivo measures of biological material properties through Reference Point Indentation (RPI).  RPI is renowned inventor Dr. Paul Hansma's most recent breakthrough designed to quantitatively measure properties that are directly related to biological tissue health and propensity to failure.  Initial applications include lab and clinical research of bone fracture risk and effects of osteoporosis treatments.  The Company is expanding its offerings to meet increasing customer demand for testing tissues in addition to bone.  Active Life's mission is to provide tools for measuring biological material properties in vivo to accelerate new strategies for the diagnosis and treatment of musculoskeletal diseases and disorders. 

Media Contact: Davis Brimer Active Life Scientific, Inc., +1.805.770.2600 x101, davis@activelifescientific.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Active Life Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
2. According to New Survey, Most Men are Not Proactive about Their Health Despite the Desire to Live Long Lives
3. Henry Schein Cares Disaster Relief Hotline is Active and Ready to Support Customers Affected by Hurricane Isaac
4. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
5. Cool Containers Introduces a Non-Dry Ice Active Container for Frozen Shipments
6. Med Ad News, PharmaLive and Pharmalot Announce the Pharma Interactive Conference in Princeton, NJ
7. How to Create Dynamic Interactive Social Learning Spaces
8. EJK Duisburg Becomes One of the Most Active SynCardia Certified Centers in Europe
9. New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
10. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
11. United Seating & Mobility Completes Acquisition of Active American Mobility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology:
(Date:4/28/2017)... Mateo, CA (PRWEB) , ... April 28, 2017 , ... ... Area cities as diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce ... allow interested persons to bookmark and read organized content on topics such as home ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement to create ... by the continuing support of the Jane and Leonard Korman Family Foundation. The ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a ... Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. ...
(Date:4/27/2017)... Malibu, CA (PRWEB) , ... April 27, 2017 , ... ... United States with an oil many times purer and more potent than the market ... mountain air of Gstaad, Switzerland, as well as a patented chromatography process for extraction, ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... today released the podcast, “Make Plans for MACRA,” highlighting the impact ... the physician's office and how physicians and other clinicians are reimbursed for the ...
Breaking Medicine News(10 mins):